These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22779791)

  • 1. Discovering the binding modes of natural products with histone deacetylase 1.
    Zhang L; Li M; Zhang L; Xu W
    Med Chem; 2013 Feb; 9(1):126-32. PubMed ID: 22779791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into structural features of HDAC1 and its selectivity inhibition elucidated by Molecular dynamic simulation and Molecular Docking.
    Sixto-López Y; Bello M; Correa-Basurto J
    J Biomol Struct Dyn; 2019 Feb; 37(3):584-610. PubMed ID: 29447615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docking of hydroxamic acids into HDAC1 and HDAC8: a rationalization of activity trends and selectivities.
    Ortore G; Di Colo F; Martinelli A
    J Chem Inf Model; 2009 Dec; 49(12):2774-85. PubMed ID: 19947584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward selective histone deacetylase inhibitor design: homology modeling, docking studies, and molecular dynamics simulations of human class I histone deacetylases.
    Wang DF; Helquist P; Wiech NL; Wiest O
    J Med Chem; 2005 Nov; 48(22):6936-47. PubMed ID: 16250652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of structural fingerprints among natural inhibitors of HDAC1 to accelerate nature-inspired drug discovery in cancer epigenetics.
    Sardar S; Jyotisha ; Amin SA; Khatun S; Qureshi IA; Patil UK; Jha T; Gayen S
    J Biomol Struct Dyn; 2024 Jul; 42(11):5642-5656. PubMed ID: 38870352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation study.
    Choubey SK; Jeyaraman J
    J Mol Graph Model; 2016 Nov; 70():54-69. PubMed ID: 27668885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for histone deacetylase activity in HDAC1-mediated transcriptional repression.
    Hassig CA; Tong JK; Fleischer TC; Owa T; Grable PG; Ayer DE; Schreiber SL
    Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3519-24. PubMed ID: 9520398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation on the isoform selectivity of histone deacetylase inhibitors using chemical feature based pharmacophore and docking approaches.
    Zhu Y; Li HF; Lu S; Zheng YX; Wu Z; Tang WF; Zhou X; Lu T
    Eur J Med Chem; 2010 May; 45(5):1777-91. PubMed ID: 20153566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic and structural insights into the binding of histone deacetylase 1 and 2 (HDAC1, 2) inhibitors.
    Wagner FF; Weïwer M; Steinbacher S; Schomburg A; Reinemer P; Gale JP; Campbell AJ; Fisher SL; Zhao WN; Reis SA; Hennig KM; Thomas M; Müller P; Jefson MR; Fass DM; Haggarty SJ; Zhang YL; Holson EB
    Bioorg Med Chem; 2016 Sep; 24(18):4008-4015. PubMed ID: 27377864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Hydroxamic Acid Based Selective HDAC1 Inhibitors: Computer Aided Drug Design Studies.
    Patel P; Patel VK; Singh A; Jawaid T; Kamal M; Rajak H
    Curr Comput Aided Drug Des; 2019; 15(2):145-166. PubMed ID: 29732991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin and hydroxamate-derivative (PCI-34058) interfere with histone deacetylase I catalytic core Asp-His charge relay system: atomistic simulation studies.
    Omotuyi IO; Abiodun MO; Komolafe K; Ejelonu OC; Olusanya O
    J Mol Model; 2015 May; 21(5):109. PubMed ID: 25860111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermodynamics of ligand binding to histone deacetylase like amidohydrolase from Bordetella/Alcaligenes.
    Meyners C; Baud MG; Fuchter MJ; Meyer-Almes FJ
    J Mol Recognit; 2014 Mar; 27(3):160-72. PubMed ID: 24446380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel N-hydroxyfurylacrylamide-based histone deacetylase (HDAC) inhibitors with branched CAP group (Part 2).
    Feng T; Wang H; Su H; Lu H; Yu L; Zhang X; Sun H; You Q
    Bioorg Med Chem; 2013 Sep; 21(17):5339-54. PubMed ID: 23820574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative molecular dynamics simulations of histone deacetylase-like protein: binding modes and free energy analysis to hydroxamic acid inhibitors.
    Yan C; Xiu Z; Li X; Li S; Hao C; Teng H
    Proteins; 2008 Oct; 73(1):134-49. PubMed ID: 18398905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring inhibitor release pathways in histone deacetylases using random acceleration molecular dynamics simulations.
    Kalyaanamoorthy S; Chen YP
    J Chem Inf Model; 2012 Feb; 52(2):589-603. PubMed ID: 22263580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding mode analysis of 3-(4-benzoyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamide: a new synthetic histone deacetylase inhibitor inducing histone hyperacetylation, growth inhibition, and terminal cell differentiation.
    Mai A; Massa S; Ragno R; Esposito M; Sbardella G; Nocca G; Scatena R; Jesacher F; Loidl P; Brosch G
    J Med Chem; 2002 Apr; 45(9):1778-84. PubMed ID: 11960489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular docking and molecular dynamics study on SmHDAC1 to identify potential lead compounds against Schistosomiasis.
    Singh R; Pandey PN
    Mol Biol Rep; 2015 Mar; 42(3):689-98. PubMed ID: 25663090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenylalanine-containing hydroxamic acids as selective inhibitors of class IIb histone deacetylases (HDACs).
    Schäfer S; Saunders L; Eliseeva E; Velena A; Jung M; Schwienhorst A; Strasser A; Dickmanns A; Ficner R; Schlimme S; Sippl W; Verdin E; Jung M
    Bioorg Med Chem; 2008 Feb; 16(4):2011-33. PubMed ID: 18054239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel series of l-2-benzyloxycarbonylamino-8-(2-pyridyl)-disulfidyloctanoic acid derivatives as histone deacetylase inhibitors: design, synthesis and molecular modeling study.
    Huang D; Li X; Wei Y; Xiu Z
    Eur J Med Chem; 2012 Jun; 52():111-22. PubMed ID: 22465091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-alkylamides as a new class of synthetic histone deacetylase inhibitors. 1. Design, synthesis, biological evaluation, and binding mode studies performed through three different docking procedures.
    Mai A; Massa S; Ragno R; Cerbara I; Jesacher F; Loidl P; Brosch G
    J Med Chem; 2003 Feb; 46(4):512-24. PubMed ID: 12570373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.